BackgroundCheck.run
Search For

Heejin K Lee, 55Lexington, MA

Known as:
Heeman Le Heeman Lee Heeman J Lee Hee Man Lee Heewon Lee Le Heeman
Related to:
Won Lee Heeman Lee Hun Lee Myoung Lee Wallace Lee Te Lee Taeyoung Lee Tae Lee 50 H Lee Young Lee 72 Byung Lee Chong Sung 54 Hunkoo Lee Myon Lee 82 Heewon Lee 58 Heejung Lee 50 James Lee 77 Heejung Lee 54 Heewon Lee 56 Yong Lee

Heejin Lee Phones & Addresses

Lexington, MA   

11 Sierra Dr, Chelmsford, MA 01824    978-2562044   

31 Dorchester St, Wilmington, MA 01887    978-9880170   

Waltham, MA   

Jewett City, CT   

Allston, MA   

Glastonbury, CT   

33 Philip Rd, Lexington, MA 02421    860-8220879   

Work

Company: School of Visual Arts

Education

School / High School: University of Iowa College of Law

Ranks

Licence: New York - Currently registered Date: 2010
Get Report
Control this profile

Mentions for Heejin K Lee

Career records & work history

Lawyers & Attorneys

Heejin Lee Photo 1

Heejin Lee - Lawyer

Address:
Lg Electronics, Inc.
023-7773218 (Office)
Licenses:
New York - Currently registered 2010
Education:
University of Iowa College of Law

Heejin Lee resumes & CV records

Resumes

Heejin Lee Photo 32

Senior Research Engineer At Taris Biomedical

Position:
Senior Research Engineer at Taris Biomedical
Location:
Greater Boston Area
Industry:
Biotechnology
Work:
Taris Biomedical since Jul 2012
Senior Research Engineer Taris Biomedical Jan 2009 - Jun 2012
Scientist
Education:
Massachusetts Institute of Technology 2004 - 2008
PhD, Mechanical Engineering Massachusetts Institute of Technology 2002 - 2004
MS, Mechanical Engineering Seoul National University
BS, Mechanical Engineering Seoul Science High School
Awards:
ISSAC Award for Innovation (IAI Award)
ISSAC Award for Innovation (IAI Award) for new advances in the field of silicone-based combination products
Basic Science Poster Winner, NIDDK New Research Directions in Urinary Incontinence Symposium
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Finalist, Collegiate Inventors Competition
National Inventors Hall of Fame Foundation
First prize winner, Excellence in Medical Device Design Prize
MIT & Ethicon Endo-Surgery, Jonhson & Johnson
Samsung Scholarship 2004-2008
Army Commendation Medal (ARCOM)
Department of The Army, USA, 2001
Certifications:
Certified SolidWorks Associate (CSWA), Dassault Systèmes SolidWorks Corp.
Heejin Lee Photo 33

Heejin Lee

Location:
United States
Heejin Lee Photo 34

Heejin Lee

Location:
Santa Clara, California
Industry:
Translation and Localization
Education:
Boston College 2006 - 2008
Master's degree, English Literature Seoul National University 2001 - 2004
Bachelor's degree, English Language and Literature
Languages:
English
Korean
Japanese
Heejin Lee Photo 35

Heejin Lee

Location:
United States

Publications & IP owners

Us Patents

Tissue Expander Configured For Drug Delivery

US Patent:
8167836, May 1, 2012
Filed:
Dec 8, 2010
Appl. No.:
12/963621
Inventors:
Heejin Lee - Arlington MA, US
Karen Daniel - Newtonville MA, US
Grace Kim - Cambridge MA, US
Michael J. Cima - Winchester MA, US
Assignee:
Taris Biomedical, Inc. - Lexington MA
International Classification:
A61M 29/00
A61L 31/16
A61F 2/12
US Classification:
60410302, 6048911, 6048921, 604 9301, 604103, 623 7, 623 8
Abstract:
A device includes a tissue expanding portion and an enclosure positioned on a surface of the tissue expanding portion. The enclosure includes an enclosure wall and a drug formulation pocket defined by the enclosure wall. A solid drug formulation that includes a drug is housed within the drug formulation pocket.

Method For Intravesical Drug Delivery

US Patent:
8182464, May 22, 2012
Filed:
Feb 22, 2010
Appl. No.:
12/709551
Inventors:
Heejin Lee - Arlington MA, US
Karen Danielle Daniel - Newtonville MA, US
Hong Linh Ho Duc - Cambridge MA, US
Michael J. Cima - Winchester MA, US
Mario Castillo - Coto Laurel PR, US
Steven Froelich - Conneaut OH, US
Jordan Dimitrakov - Boston MA, US
Grace Y. Kim - Cambridge MA, US
Assignee:
Massachusetts Institute of Technology - Cambridge MA
Children's Medical Center Corporation - Boston MA
International Classification:
A61M 31/00
A01N 43/04
A01N 37/12
A01N 37/44
A01N 43/38
A01N 37/18
A01N 59/02
A61K 31/24
A61K 31/40
A61K 31/16
A61K 33/04
US Classification:
604517, 514 54, 514534, 514411, 514626, 604500, 424703
Abstract:
Implant devices for intravesical administration and local drug delivery. The device has a body which includes a hollow tube formed of a biocompatible material; at least one reservoir in the tube which contains a drug; and one or more apertures through which the drug can be released. The device is configured for minimally invasive insertion into a body cavity, such as the bladder. The hollow tube may be elastomeric to permit the device to be elastically deformed from its initial shape into an elongated shape for passage through a catheter, where following such passage the device can return to or toward its initial shape to facilitate retention of the device in the body cavity. The body may have a narrow, elongated shape effective to permit insertion of the drug delivery device through a catheter without necessarily deforming the body, yet include flexible projections which effect retention within the body cavity.

Solid Drug Tablets For Implantable Drug Delivery Devices

US Patent:
8343516, Jan 1, 2013
Filed:
Jun 28, 2010
Appl. No.:
12/825238
Inventors:
Karen Danielle Daniel - Newtonville MA, US
Heejin Lee - Arlington MA, US
Assignee:
TARIS Biomedical, Inc. - Lexington MA
International Classification:
A61F 13/00
A61F 2/02
US Classification:
424400, 424422
Abstract:
A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesethetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e. g. , one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.

Intravesical Drug Delivery Device And Method

US Patent:
2007020, Aug 30, 2007
Filed:
Aug 11, 2006
Appl. No.:
11/463956
Inventors:
Heejin Lee - Cambridge MA, US
Karen Daniel - Newtonville MA, US
Hong Ho Duc - Cambridge MA, US
Michael Cima - Winchester MA, US
Jordan Dimitrakov - Boston MA, US
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
CHILDREN'S MEDICAL CENTER CORPORATION - BOSTON MA
International Classification:
A61F 2/02
US Classification:
424426000
Abstract:
Implant devices for intravesical administration and local drug delivery. The device has a body which includes a hollow tube formed of a biocompatible material; at least one reservoir in the tube which contains a drug; and one or more apertures through which the drug can be released. The device is configured for minimally invasive insertion into a body cavity, such as the bladder. The hollow tube may be elastomeric to permit the device to be elastically deformed from its initial shape into an elongated shape for passage through a catheter, where following such passage the device can return to or toward its initial shape to facilitate retention of the device in the body cavity. The body may have a narrow, elongated shape effective to permit insertion of the drug delivery device through a catheter without necessarily deforming the body, yet include flexible projections which effect retention within the body cavity.

Implantable Drug Delivery Device And Methods For Treatment Of The Bladder And Other Body Vesicles Or Lumens

US Patent:
2009014, Jun 11, 2009
Filed:
Dec 11, 2008
Appl. No.:
12/333182
Inventors:
Michael J. Cima - Winchester MA, US
Heejin Lee - Cambridge MA, US
Assignee:
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - Cambridge MA
International Classification:
A61M 25/00
A61K 31/167
US Classification:
604517, 604 9301, 604264, 604523, 514626
Abstract:
An implantable medical device is provided for controlled drug delivery within the bladder, or other body vesicle. The device may include at least one drug reservoir component comprising a drug; and a vesicle retention frame which comprises an elastic wire having a first end, an opposing second end, and an intermediate region therebetween, wherein the drug reservoir component is attached to the intermediate region of the vesicle retention frame. The retention frame prevents accidental voiding of the device from the bladder, and it preferably has a spring constant selected for the device to effectively stay in the bladder during urination while minimizing the irritation of the bladder.

Implantable Drug Delivery Device And Methods Of Treating Male Genitourinary And Surrounding Tissues

US Patent:
2010000, Jan 7, 2010
Filed:
Aug 10, 2009
Appl. No.:
12/538580
Inventors:
Irene Sophie Tobias - Cambridge MA, US
Heejin Lee - Arlington MA, US
Michael J. Cima - Winchester MA, US
Jordan Dimitrakov - Boston MA, US
Assignee:
Massachusetts Institute of Technology - Cambridge MA
Children's Medical Center Corporation - Boston MA
International Classification:
A61K 9/00
A61P 43/00
US Classification:
424422
Abstract:
A method is provided for local controlled delivery of a drug to the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of a patient in need of treatment. In one embodiment, the method includes implanting a resorbable drug delivery device within the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens of the patient. The drug delivery device may include an elastic device body housing at least one drug reservoir which contains at least one drug. In a preferred embodiment, the method further includes releasing the drug from the device in a controlled manner to, typically directly to, the seminal vesicle, the prostate, the ejaculatory duct, or the vas deferens.

Implantable Drug Delivery Devices And Methods Of Making The Same

US Patent:
2010033, Dec 30, 2010
Filed:
Jun 28, 2010
Appl. No.:
12/825215
Inventors:
Heejin Lee - Arlington MA, US
Assignee:
TARIS BIOMEDICAL, INC. - Lexington MA
International Classification:
A61M 31/00
B65D 83/04
US Classification:
604 57, 221 1, 221199
Abstract:
A drug delivery device is provided that includes a device body, a number of solid, compressed drug tablets, and a retention frame. The device body includes a drug reservoir lumen and a retention frame lumen. The number of solid, compressed drug tablets are positioned in the drug reservoir lumen, and the retention frame is positioned in the retention frame lumen. The drug tablets may be mini-tablets aligned in the drug reservoir lumen, with an interstice formed between any two adjacent drug tablets facilitating deformation of the device body. Systems and method are also provided for loading a drug delivery device. In one embodiment, the method includes positioning one or more solid drug units upstream of the drug delivery device; and driving the drug units into the drug delivery device with a flow of pressurized gas.

Minimally Invasive Systems And Methods For In Vivo Testing Of Materials

US Patent:
2011005, Mar 3, 2011
Filed:
Aug 27, 2010
Appl. No.:
12/870261
Inventors:
Heejin Lee - Arlington MA, US
Assignee:
TARIS BIOMEDICAL, INC. - Lexington MA
International Classification:
A61K 49/00
C12Q 1/02
C12M 1/34
G01N 31/00
US Classification:
424 91, 435 29, 4352871, 436 5
Abstract:
Implantable material testing devices and method of testing materials in an animals are provided. In one embodiment, a method of testing a material in an animal includes associating the material with a retention frame to form a testing device. The retention frame movable between a first shape suited for insertion through a deployment instrument and a second shape suited for retention in the animal. The testing device is inserted in the first shape into the deployment instrument and is driven through the deployment instrument into the animal. Once in the animal, the testing device is permitted to assume the second shape so that the testing device is retained in the animal for a testing period. The testing device is removed from the animal after the testing period is complete, and the material is analyzed. The material may be analyzed for biofilm formation, encrustation, or degradation. The animal also may be analyzed for infection or other reactions to the material. Tissue may be collected from the animal, and the tissue may be analyzed. The testing period may be between about 1 day and about 90 days.

Possible Relatives

Cynthia C Lee  Davis Lee  Dawn P Lee  Dean M Lee  Dae S Lee  Deanna L Lee  Daina M Lee  Heejin J Ko  Heejin S Kwon 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.